President Trump met U.S. Steel CEO David Buritt at the White House. They discussed a blocked merger with Japan's Nippon Steel ...

The CMS said it’s working with the Department of Government Efficiency to find “opportunities for more effective and ...

DeRemer, who previously served in the House, could pave the way for action on PBMs and mental health benefits.

President Donald Trump was handed an opportunity to "save" Medicare Advantage after the Biden administration's final proposal ...

Money and health insurance red tape remain central to healthcare interest groups such as the American Hospital Association, ...

Donald Trump’ s return to the White House- along with a GOP- controlled Senate and House of Representatives- is expected to change that. Republicans in Washington say they plan to use funding cuts and ...

While several Democrats expressed outrage over the possibility that President Donald Trump’s temporary federal spending ...

The DOJ’s career pardon attorney told prosecutors that some of Biden’s moves to shorten sentences were “very upsetting.” ...

Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

Since taking office for his second term on Jan. 20, 2025, President Donald Trump has issued a series of executive orders (EOs) aimed at ...

The Chicago-based association will also "pick and choose" its advocacy fights regarding topics like vaccines, gender ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...